Ad
related to: mustard atrial switch procedure instructions
Search results
Results From The WOW.Com Content Network
The Mustard procedure was developed in 1963 by Dr. William Mustard at the Hospital for Sick Children.It is similar to the previous atrial baffle used with a Senning procedure, the primary difference being that the Mustard uses a graft made of Dacron or pericardium, while the Senning uses native heart tissue.
Two variants of the atrial switch operation developed – the Senning procedure (1950s) which uses the patient's own tissue (pericardium) to construct the baffle, and the Mustard procedure (1960s), which uses a synthetic material. [4] It has largely been replaced by the arterial switch operation. [4]
Arterial switch operation (ASO) or arterial switch, is an open heart surgical procedure used to correct dextro-transposition of the great arteries (d-TGA). [1] [2]Its development was pioneered by Canadian cardiac surgeon William Mustard and it was named for Brazilian cardiac surgeon Adib Jatene, who was the first to use it successfully.
In the case of sepsis or late diagnosis, a delayed Arterial Switch can sometimes be made possible by PAB, which may also require a concomitant construction of an aortic-to-pulmonary artery shunt. [2] When an arterial switch is impossible, an atrial switch will be attempted using either the Senning or Mustard procedure. [7]
In this scenario, a second procedure with an atrial switch is done after recovery from the first intervention. The atrial switch is done via either the Mustard procedure, in which the atrial septum is cut out and a baffle is made with the pericardial baffle, or a Senning procedure, in which the atrial septum itself is used to create the baffle.
The system, PulseSelect Pulsed Field Ablation (PFA), is used for the treatment of atrial fibrillation (AF), a condition that is characterized by an irregular rhythm of the heart.
The Senning procedure is an atrial switch heart operation performed to treat transposition of the great arteries. It is named after its inventor, the Swedish cardiac surgeon Åke Senning (1915–2000), also known for implanting the first permanent cardiac pacemaker in 1958.
The Blalock–Thomas–Taussig shunt (BTT shunt), [1] previously known as the Blalock–Taussig Shunt (BT shunt), [2] is a surgical procedure used to increase blood flow to the lungs in some forms of congenital heart disease [3] such as pulmonary atresia and tetralogy of Fallot, which are common causes of blue baby syndrome. [3]